The recent approval of immune checkpoint inhibitors (ICI) revolutionized the treatment paradigm for metastatic renal cell carcinoma (mRCC). However, the role of cytoreductive nephrectomy is not well defined in this setting. Here, we review the contemporary role and timing of cytoreductive nephrectomy for advanced RCC in the era of immunotherapy. ...
The LARCG (Latin American Renal Cancer Group) is a group of scientific and educational, multicentric, multidisciplinary and independent. It is not for profit, and the term of operation is indeterminate. It consists of Urologists, Pathologists and Oncologists, as well as professionals and researchers related to the field of health, belonging to Hospitals in Latin America, Spain and the United States.
New: ESMO 2019 Highlights for #kidneycancer patient organisations from the International Kidney Cancer Coalition #ESMO19 https://t.co/Z7Ni64njaT
Briefly two new papers in RCC:PDL1 expression in more than 1000 cases, from AC Camargo, @larcg_org Lee Moffitt @SpiessPhilippe Juan Chipollini.
And bad prognostic in negative Ezrin expression in 575ccRcc, from @acccancercenter @larcg_org Proud!
